Statistical evaluation of the scaled criterion for drug interchangeability
暂无分享,去创建一个
[1] S. Chow,et al. Some thoughts on drug interchangeability , 2016, Journal of Biopharmaceutical Statistics.
[2] S. Chow. Assessing biosimilarity and interchangeability of biosimilar products under the Biologics Price Competition and Innovation Act , 2013 .
[3] A Comparison Model for Measuring Individual Agreement , 2013, Journal of biopharmaceutical statistics.
[4] A. S. Hedayat,et al. Statistical Tools for Measuring Agreement , 2011 .
[5] Lawrence X. Yu,et al. Bioequivalence Approaches for Highly Variable Drugs and Drug Products , 2007, Pharmaceutical Research.
[6] Shein-Chung Chow,et al. Modified Large-Sample Confidence Intervals for Linear Combinations of Variance Components , 2004 .
[7] Thomas Mathew,et al. Tests for individual and population bioequivalence based on generalized p‐values , 2003, Statistics in medicine.
[8] W. Hauck,et al. An individual bioequivalence criterion: regulatory considerations. , 2000, Statistics in medicine.
[9] L. Endrenyi,et al. Properties of the estimated variance component for subject-by-formulation interaction in studies of individual bioequivalence. , 2000, Statistics in medicine.
[10] S. Chow. Individual Bioequivalence—A Review of the FDA Draft Guidance , 1999 .
[11] E. Cornish,et al. The Percentile Points of Distributions Having Known Cumulants , 1960 .